Details for 2012154995

Up to date per 01.04.2026

Actions

Title / Product Name

Nanoteilchen von Paclitaxel und Albumin in Kombination mit Bevacizumab gegen Krebs

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2012154995

EP Publication Number

2481405

E-Number

782441

Language

PCT Number

Publication Date

01.08.2012 A

23.03.2016 B1

Registration Date

23.03.2016

AT Publication Date

15.04.2016

Application Date

06.11.2007

Registration Number

Priorities

06.11.2006

594417

IPC

A61K 31/337 20060101AFI20120627BHEP

Maximum Duration of Protection

06.11.2027

Owner

Abraxis BioScience, LLC86 Morris Avenue, Summit New Jersey 07901US

Representative

Patentanwälte Puchberger & PartnerReichsratsstraße 131010 WienAT

Inventor

Desai, Neil P.11755 Wilshire Boulevard, Suite 2000 Los Angeles, CA 90025US

Soon-Shiong, Patrick149 South Barrington Avenue, 311 Los Angeles, CA 90049US

Information about Fees